Entrada Therapeutics, Inc.
TRDA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001689375
In the last 90 days, Entrada Therapeutics, Inc. insiders filed 0 open-market purchases and 7 sales; 128 institutions reported holding it in 13F filings for Q2 2026, worth $214.4M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Entrada Therapeutics, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 47
- +14 vs. Q3 2022
- Shares held
- 24.7M
- +198.6K (+0.8%) vs. Q3 2022
- Total value
- $334.2M
- −$52.2M (−13.5%) vs. Q3 2022
- New holders
- 17
- 16 more added
- Sold out
- 3
- 6 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TRDA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 128 | $214.4M |
| Q1 2026 | 119 | $321.4M |
| Q4 2025 | 113 | $251.0M |
| Q3 2025 | 116 | $164.8M |
| Q2 2025 | 107 | $198.8M |
| Q1 2025 | 110 | $274.5M |
| Q4 2024 | 102 | $529.8M |
| Q3 2024 | 97 | $481.1M |
| Q2 2024 | 84 | $423.1M |
| Q1 2024 | 77 | $368.8M |
| Q4 2023 | 62 | $396.6M |
| Q3 2023 | 55 | $411.4M |
| Q2 2023 | 56 | $389.9M |
| Q1 2023 | 53 | $361.0M |
| Q4 2022 | 47 | $334.2M |
| Q3 2022 | 33 | $386.4M |
| Q2 2022 | 38 | $301.8M |
| Q1 2022 | 48 | $242.8M |
| Q4 2021 | 46 | $433.8M |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Entrada Therapeutics, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Royal Bank of Canada | 28 | $0 | 0.00% | +28 | New |
| Wells Fargo & Company | 168 | $2.27K | 0.00% | +3+1.8% | Added |
| Advisor Group Holdings, Inc. | 300 | $4.00K | 0.00% | 00.0% | Unchanged |
| Cubist Systematic Strategies, LLC | 405 | $5.48K | 0.00% | −600−59.7% | Reduced |
| Tower Research Capital LLC (TRC) | 447 | $6.00K | 0.00% | −2,061−82.2% | Reduced |
| UBS Group AG | 1,257 | $17.0K | 0.00% | +1,257 | New |
| Legal & General Group Plc | 2,937 | $39.7K | 0.00% | +2,937 | New |
| Bank of America Corp | 5,296 | $71.6K | 0.00% | +1,330+33.5% | Added |
| JPMorgan Chase & Co | 7,593 | $103.0K | 0.00% | +7,593 | New |
| Credit Suisse AG | 8,811 | $119.1K | 0.00% | +8,811 | New |
| California State Teachers Retirement System | 9,514 | $128.6K | 0.00% | +9,514 | New |
| 683 Capital Management, LLC | 10,355 | $140.0K | 0.01% | +10,355 | New |
| Barclays PLC | 10,772 | $145.6K | 0.00% | +9,557+786.6% | Added |
| State of Wisconsin Investment Board | 10,971 | $148.3K | 0.00% | +10,971 | New |
| Balyasny Asset Management LLC | 12,132 | $164.0K | 0.00% | +12,132 | New |
| Bank of New York Mellon Corp | 12,439 | $168.2K | 0.00% | +12,439 | New |
| Ergoteles LLC | 14,019 | $189.5K | 0.01% | +14,019 | New |
| Jane Street Group, LLC | 14,524 | $196.4K | 0.00% | +14,524 | New |
| Qube Research & Technologies Ltd | 16,782 | $226.9K | 0.00% | +16,782 | New |
| Morgan Stanley | 24,886 | $336.5K | 0.00% | +14,356+136.3% | Added |
| Natixis | 26,186 | $354.0K | 0.00% | +26,186 | New |
| Swiss National Bank | 26,500 | $358.3K | 0.00% | +26,500 | New |
| Northern Trust Corp | 34,360 | $464.5K | 0.00% | +4,363+14.5% | Added |
| Millennium Management LLC | 39,894 | $539.0K | 0.00% | +39,894 | New |
| Manufacturers Life Insurance Company, The | 41,206 | $581.5K | 0.00% | +31+0.1% | Added |
| Citigroup Inc | 51,042 | $690.1K | 0.00% | +49,459+3,124.4% | Added |
| TD Asset Management Inc | 59,627 | $806.2K | 0.00% | +131+0.2% | Added |
| State Street Corp | 64,523 | $872.4K | 0.00% | +31,229+93.8% | Added |
| Nan Fung Group Holdings Ltd | 73,582 | $994.8K | 0.69% | −68,011−48.0% | Reduced |
| Charles Schwab Investment Management Inc | 88,970 | $1.20M | 0.00% | +1,111+1.3% | Added |
| Moore Capital Management, LP | 105,000 | $1.42M | 0.04% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 111,797 | $1.51M | 0.00% | +111,797 | New |
| Geode Capital Management, LLC | 181,957 | $2.46M | 0.00% | +14,839+8.9% | Added |
| BlackRock Inc. | 187,994 | $2.54M | 0.00% | +40,401+27.4% | Added |
| Laurion Capital Management LP | 199,066 | $2.69M | 0.08% | 00.0% | Unchanged |
| Goldman Sachs Group Inc | 402,039 | $5.44M | 0.00% | −47,954−10.7% | Reduced |
| FMR LLC | 503,911 | $6.81M | 0.00% | +40.0% | Added |
| 72 Investment Holdings, LLC | 509,023 | $6.88M | 3.16% | 00.0% | Unchanged |
| TCG Crossover Management, LLC | 584,955 | $7.91M | 1.40% | −57,234−8.9% | Reduced |
| StepStone Group LP | 761,277 | $10.3M | 1.35% | 00.0% | Unchanged |
| Vanguard Group Inc | 920,253 | $12.4M | 0.00% | +50,106+5.8% | Added |
| Wellington Management Group LLP | 1,010,351 | $13.7M | 0.00% | +3,105+0.3% | Added |
| Redmile Group, LLC | 1,854,108 | $25.1M | 1.03% | −100,311−5.1% | Reduced |
| Price T Rowe Associates Inc | 3,014,377 | $40.8M | 0.01% | +42,327+1.4% | Added |
| 5AM Venture Management, LLC | 4,408,379 | $59.6M | 16.02% | 00.0% | Unchanged |
| MPM Asset Management LLC | 4,425,784 | $59.8M | 25.04% | 00.0% | Unchanged |
| Baker Bros. Advisors LP | 4,865,819 | $65.8M | 0.40% | 00.0% | Unchanged |
| Invesco Ltd. | 0 | $0 | 0.00% | −95,209−100.0% | Sold out |
| Fred Alger Management, LLC | 0 | $0 | 0.00% | −17,955−100.0% | Sold out |
| BNP Paribas Arbitrage, SA | 0 | $0 | 0.00% | −198−100.0% | Sold out |